Tzeyu L Michaud1,2, Mohammad Siahpush2, Paraskevi A Farazi3, Jungyoon Kim4, Fang Yu5, Dejun Su1,2, Daniel L Murman6. 1. Center for Reducing Health Disparities, College of Public Health, University of Nebraska, Medical Center, Omaha, NE, USA. 2. Department of Health Promotion, College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA. 3. Department of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA. 4. Department of Health Services Research & Administration, College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA. 5. Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA. 6. Behavioral and Geriatric Neurology Program, Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Abstract
BACKGROUND: Association between high adiposity and the clinical progression of dementia remains puzzling. OBJECTIVE: To separately examine the association between body mass index (BMI) and cognitive, functional, and behavioral declines before, at, and after diagnosis of dementia, and further stratified by age groups, and sex. METHODS: A total of 1,141 individuals with incident dementia were identified from the Uniform Data Set of the National Alzheimer's Coordinating Center. Cognitive function was evaluated by Mini-Mental State Exam, functional abilities were assessed using Functional Activities Questionnaire, and behavioral symptoms were captured by Neuropsychiatric Inventory Questionnaire at each follow-up visit. We used separate linear-mixed effects models to examine the association. RESULTS: Compared to moderate baseline BMI, high baseline BMI was associated with 0.30-point slower annual progression rates in functional decline. For individuals aged 76 and over, high baseline BMI was associated with 0.42-point faster progression rates in cognitive decline annually. A U-shaped association between baseline BMI and cognitive decline was observed among men. CONCLUSION: BMI levels before dementia diagnosis may facilitate the identification of different risk profiles for progression rates of cognitive and functional declines in individuals who developed dementia.
BACKGROUND: Association between high adiposity and the clinical progression of dementia remains puzzling. OBJECTIVE: To separately examine the association between body mass index (BMI) and cognitive, functional, and behavioral declines before, at, and after diagnosis of dementia, and further stratified by age groups, and sex. METHODS: A total of 1,141 individuals with incident dementia were identified from the Uniform Data Set of the National Alzheimer's Coordinating Center. Cognitive function was evaluated by Mini-Mental State Exam, functional abilities were assessed using Functional Activities Questionnaire, and behavioral symptoms were captured by Neuropsychiatric Inventory Questionnaire at each follow-up visit. We used separate linear-mixed effects models to examine the association. RESULTS: Compared to moderate baseline BMI, high baseline BMI was associated with 0.30-point slower annual progression rates in functional decline. For individuals aged 76 and over, high baseline BMI was associated with 0.42-point faster progression rates in cognitive decline annually. A U-shaped association between baseline BMI and cognitive decline was observed among men. CONCLUSION: BMI levels before dementia diagnosis may facilitate the identification of different risk profiles for progression rates of cognitive and functional declines in individuals who developed dementia.
Entities:
Keywords:
Behavior; body mass index; cognition; dementia; disease progression; neuropsychological tests; public health
Authors: Lilah M Besser; Dawn P Gill; Sarah E Monsell; Willa Brenowitz; Dana H Meranus; Walter Kukull; Deborah R Gustafson Journal: Alzheimer Dis Assoc Disord Date: 2014 Jan-Mar Impact factor: 2.703
Authors: A Coin; N Veronese; M De Rui; M Mosele; F Bolzetta; A Girardi; E Manzato; G Sergi Journal: J Nutr Health Aging Date: 2012 Impact factor: 4.075
Authors: Sally A Shumaker; Claudine Legault; Stephen R Rapp; Leon Thal; Robert B Wallace; Judith K Ockene; Susan L Hendrix; Beverly N Jones; Annlouise R Assaf; Rebecca D Jackson; Jane Morley Kotchen; Sylvia Wassertheil-Smoller; Jean Wactawski-Wende Journal: JAMA Date: 2003-05-28 Impact factor: 56.272
Authors: Lilah M Besser; Michael L Alosco; Liliana Ramirez Gomez; Xiao-Hua Zhou; Ann C McKee; Robert A Stern; John Gunstad; Julie A Schneider; Helena Chui; Walter A Kukull Journal: J Neuropathol Exp Neurol Date: 2016-08-11 Impact factor: 3.685
Authors: Kasim Ortiz; Marc A Garcia; Emily Briceño; Erica D Diminich; Sandra P Arévalo; Irving E Vega; Wassim Tarraf Journal: Res Hum Dev Date: 2020-07-01
Authors: Sami Ouanes; Christopher Clark; Jonas Richiardi; Bénédicte Maréchal; Piotr Lewczuk; Johannes Kornhuber; Clemens Kirschbaum; Julius Popp Journal: Front Aging Neurosci Date: 2022-07-07 Impact factor: 5.702